GE HealthCare Technologies (US.GEHC)
Capital Allocation Audit · Period: 2019 – 2026
Key Metrics
US.GEHC · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 39.3% | ↑ |
| ROE | 8.7% | ↓ |
| Cash Conversion | 48.2% | ↑ |
| D/E Ratio | 0.96 | ↑ |
| Gross Margin | 39.9% | → |
US.GEHC (GE HealthCare Technologies) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY --------------------------- FCF Conversion 39.3% ↑ ROE 8.7% ↓ Cash Conversion 48.2% ↑ D/E Ratio 0.96 ↑ Gross Margin 39.9% →
Key Metrics
US.GEHC (GE HealthCare Technologies) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY---------------------------FCF Conversion 39.3% ↑ROE 8.7% ↓Cash Conversion 48.2% ↑D/E Ratio 0.96 ↑Gross Margin 39.9% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies